Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis

Ji Young Hong, Gyeong Seo Jung, Hyunjung Kim, Young Mi Kim, Hye Jon Lee, Sangnae Cho, Se Kyu Kim, Joon Chang, youngae kang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: This study evaluated inducible protein 10 (IP-10) as a diagnostic biomarker for specific tuberculosis (TB) infection and evaluated the ability of IP-10 to distinguish between active TB and latent TB infection (LTBI). Methods: Forty-six patients with active pulmonary TB, 22 participants with LTBI, and 32 non-TB controls were enrolled separately. We measured IP-10 in serum and in supernatants from whole blood stimulated with TB-specific antigens. Results: TB antigen-dependent IP-10 secretion was significantly increased in the active TB patients and LTBI subjects compared with controls, but did not differ significantly between the active TB patients and LTBI subjects. Serum IP-10 levels were higher in active TB than in LTBI (174.9 vs. 102.7. pg/ml, p=0.002). The respective rates of positive responders of TB antigen-dependent IP-10 were 97.8%, 90.9%, and 12.5% in active TB, LTBI, and non-TB controls, respectively. For serum IP-10, 87.5%, 45.5%, and 9.5% of responders were positive in the respective groups. Conclusions: The IP-10 response to TB antigen may constitute a specific biomarker for TB infection, but does not by itself distinguish between active TB and LTBI. Serum IP-10 may enhance the diagnostic performance when used in combination with another marker.

Original languageEnglish
JournalInternational Journal of Infectious Diseases
Volume16
Issue number12
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Latent Tuberculosis
Tuberculosis
Biomarkers
Infection
Proteins
Antigens
Blood Proteins
Pulmonary Tuberculosis
Serum

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Hong, Ji Young ; Jung, Gyeong Seo ; Kim, Hyunjung ; Kim, Young Mi ; Lee, Hye Jon ; Cho, Sangnae ; Kim, Se Kyu ; Chang, Joon ; kang, youngae. / Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. In: International Journal of Infectious Diseases. 2012 ; Vol. 16, No. 12.
@article{e975abd14e164f86a081b0af5cf1667e,
title = "Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis",
abstract = "Objective: This study evaluated inducible protein 10 (IP-10) as a diagnostic biomarker for specific tuberculosis (TB) infection and evaluated the ability of IP-10 to distinguish between active TB and latent TB infection (LTBI). Methods: Forty-six patients with active pulmonary TB, 22 participants with LTBI, and 32 non-TB controls were enrolled separately. We measured IP-10 in serum and in supernatants from whole blood stimulated with TB-specific antigens. Results: TB antigen-dependent IP-10 secretion was significantly increased in the active TB patients and LTBI subjects compared with controls, but did not differ significantly between the active TB patients and LTBI subjects. Serum IP-10 levels were higher in active TB than in LTBI (174.9 vs. 102.7. pg/ml, p=0.002). The respective rates of positive responders of TB antigen-dependent IP-10 were 97.8{\%}, 90.9{\%}, and 12.5{\%} in active TB, LTBI, and non-TB controls, respectively. For serum IP-10, 87.5{\%}, 45.5{\%}, and 9.5{\%} of responders were positive in the respective groups. Conclusions: The IP-10 response to TB antigen may constitute a specific biomarker for TB infection, but does not by itself distinguish between active TB and LTBI. Serum IP-10 may enhance the diagnostic performance when used in combination with another marker.",
author = "Hong, {Ji Young} and Jung, {Gyeong Seo} and Hyunjung Kim and Kim, {Young Mi} and Lee, {Hye Jon} and Sangnae Cho and Kim, {Se Kyu} and Joon Chang and youngae kang",
year = "2012",
month = "12",
day = "1",
doi = "10.1016/j.ijid.2012.07.013",
language = "English",
volume = "16",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "12",

}

Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. / Hong, Ji Young; Jung, Gyeong Seo; Kim, Hyunjung; Kim, Young Mi; Lee, Hye Jon; Cho, Sangnae; Kim, Se Kyu; Chang, Joon; kang, youngae.

In: International Journal of Infectious Diseases, Vol. 16, No. 12, 01.12.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis

AU - Hong, Ji Young

AU - Jung, Gyeong Seo

AU - Kim, Hyunjung

AU - Kim, Young Mi

AU - Lee, Hye Jon

AU - Cho, Sangnae

AU - Kim, Se Kyu

AU - Chang, Joon

AU - kang, youngae

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Objective: This study evaluated inducible protein 10 (IP-10) as a diagnostic biomarker for specific tuberculosis (TB) infection and evaluated the ability of IP-10 to distinguish between active TB and latent TB infection (LTBI). Methods: Forty-six patients with active pulmonary TB, 22 participants with LTBI, and 32 non-TB controls were enrolled separately. We measured IP-10 in serum and in supernatants from whole blood stimulated with TB-specific antigens. Results: TB antigen-dependent IP-10 secretion was significantly increased in the active TB patients and LTBI subjects compared with controls, but did not differ significantly between the active TB patients and LTBI subjects. Serum IP-10 levels were higher in active TB than in LTBI (174.9 vs. 102.7. pg/ml, p=0.002). The respective rates of positive responders of TB antigen-dependent IP-10 were 97.8%, 90.9%, and 12.5% in active TB, LTBI, and non-TB controls, respectively. For serum IP-10, 87.5%, 45.5%, and 9.5% of responders were positive in the respective groups. Conclusions: The IP-10 response to TB antigen may constitute a specific biomarker for TB infection, but does not by itself distinguish between active TB and LTBI. Serum IP-10 may enhance the diagnostic performance when used in combination with another marker.

AB - Objective: This study evaluated inducible protein 10 (IP-10) as a diagnostic biomarker for specific tuberculosis (TB) infection and evaluated the ability of IP-10 to distinguish between active TB and latent TB infection (LTBI). Methods: Forty-six patients with active pulmonary TB, 22 participants with LTBI, and 32 non-TB controls were enrolled separately. We measured IP-10 in serum and in supernatants from whole blood stimulated with TB-specific antigens. Results: TB antigen-dependent IP-10 secretion was significantly increased in the active TB patients and LTBI subjects compared with controls, but did not differ significantly between the active TB patients and LTBI subjects. Serum IP-10 levels were higher in active TB than in LTBI (174.9 vs. 102.7. pg/ml, p=0.002). The respective rates of positive responders of TB antigen-dependent IP-10 were 97.8%, 90.9%, and 12.5% in active TB, LTBI, and non-TB controls, respectively. For serum IP-10, 87.5%, 45.5%, and 9.5% of responders were positive in the respective groups. Conclusions: The IP-10 response to TB antigen may constitute a specific biomarker for TB infection, but does not by itself distinguish between active TB and LTBI. Serum IP-10 may enhance the diagnostic performance when used in combination with another marker.

UR - http://www.scopus.com/inward/record.url?scp=84869229752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869229752&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2012.07.013

DO - 10.1016/j.ijid.2012.07.013

M3 - Article

VL - 16

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 12

ER -